Drugs could impact COVID-19 infection via other MoA

  • The in vitro EC50 are all informing on antiviral activity but some of these drugs could impact covid19 infection via other moa. Are you thinking of extending your platform to account for that ?

    We are currently developing viral kinetic simulations to address these, as well as combo drugs which usually bring multiple MoAs.

  • You must be logged in to reply to this topic.